Baird Melissa's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Apr 23, 2025
- Accession no.
- 0001773751-25-000133
- Filed
- Apr 23, 2025
- Trade date
- Apr 21, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $859.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Baird MelissaCIK 0001837815 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | Class A Common Stock | MOption exerciseAcquired | +22,568 | $1.75 | +$39,494 | 827,651 | Direct | |
| Apr 21, 2025 | Class A Common Stock | MOption exerciseAcquired | +10,765 | $2.43 | +$26,158.95 | 838,416 | Direct | |
| Apr 21, 2025 | Class A Common Stock | SSaleDisposed | −27,035 | $25.66F2 | −$693,718.1 | 811,381 | Direct | |
| Apr 21, 2025 | Class A Common Stock | SSaleDisposed | −6,298 | $26.29F3 | −$165,574.42 | 805,083 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2025 | Class A Common Stock | MOption exerciseDisposed | −22,568 | $0.00 | $0 | 0 | Direct | |
| Apr 21, 2025 | Class A Common Stock | MOption exerciseDisposed | −10,765 | $0.00 | $0 | 727,128 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.29 - $25.98. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.055 - $26.69. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.